Nine Months Ended June 30, 2020 versus June 30, 2019
Net revenue for the nine months ended June 30, 2020 and 2019 were $66,963,000 and $66,845,000, respectively, an increase of $118,000.
Gross profit margins decreased to 25.5% in the nine months ended June 30, 2020 from 29.3% in the nine months ended June 30, 2019. The gross profit margins achieved in the prior year benefitted from an unusually strong pricing environment for plant and equipment sales.
Product engineering and development expenses decreased by $123,000 in the nine months ended June 30, 2020, compared to the nine months ended June 30, 2019. SG&A expenses increased $330,000 in the nine months ended June 30, 2020, compared to the nine months ended June 30, 2019. As a percentage of net revenues, SG&A expenses were 11.1% for the nine months ended June 30, 2020, compared to 10.7% for the nine months ended June 30, 2019. The higher SG&A expenses in 2020 were due to increased headcount, travel and trade show expenses during the first nine months of fiscal 2020.
The Company had operating income of $7,274,000 for the nine months ended June 30, 2020 versus operating income of $10,016,000 for the nine months ended June 30, 2019, on lower gross profit margins and higher SG&A expenses. Operating margins were 10.9% for the nine months ended June 30, 2020, compared to 15.0% for the nine months ended June 30, 2019.
For the nine months ended June 30, 2020, interest and dividend income, net of fees, from the investment portfolio was $1,907,000, as compared to $1,608,000 for the prior period. The increase was due to additional interest income from a larger investment in corporate bonds and higher average yield to maturities. The net realized and unrealized losses on marketable securities were $(1,465,000) for the nine months ended June 30, 2020 versus net realized and unrealized gains of $1,147,000 for the nine months ended June 30, 2019. The current year investment losses reflect the decline in the domestic equity markets from the impact of the
COVID-19
pandemic.
The effective income tax rate for the nine months ended June 30, 2020 and June 30, 2019 was 20.0%. Net income for the nine months ended June 30, 2020 was $6,156,000, or $0.42 per diluted share, versus $10,217,000, or $0.69 per diluted share, for the nine months ended June 30, 2019.
In March 2020, the WHO declared the outbreak of
COVID-19
as a pandemic based on the rapid increase in global exposure.
COVID-19
continues to spread throughout world, including the United States. The
COVID-19
pandemic continues to impact economic conditions, which could impact the short-term and long-term demand from our customers and, therefore, has the potential to negatively impact our results of operations, cash flows, and financial position in the future. Management continues to monitor the situation and any impact on our financial condition and results of operations.
Liquidity and Capital Resources
The Company generates capital resources through operations and returns on its investments.
The Company had no long-term or short-term debt outstanding at June 30, 2020 or September 30, 2019. As of June 30, 2020, the Company has funded $85,000 in cash deposits at insurance companies to cover related collateral needs. In April 2020, a financial institution issued an irrevocable standby letter of credit (“letter of credit”) on behalf of the Company for the benefit of one of the Company’s insurance carriers. The maximum amount that can be drawn by the beneficiary under the letter of credit is $150,000. The letter of credit expires in April 2021, unless terminated earlier, and can be extended, as provided by the agreement. The Company intends to renew the letter of credit for as long as the Company does business with the beneficiary insurance carrier. The letter is collateralized by restricted cash of the same amount on any outstanding drawings. To date, no amounts have been drawn under the letter of credit.